Hongxia Lu

机构：New Jersey Institute of Technology, Hefei Normal University, Shanxi Medical University, Zhengzhou University, Zhengzhou University of Science and Technology, Shanxi Provincial Cancer Hospital, Shenzhen Bao'an District People's Hospital, Cancer Hospital of Chinese Academy of Medical Sciences, China Academy of Railway Sciences · ORCID：0009-0007-6057-1832

发表论文 30 篇 · 总被引 98 次 · h-index 5

代表论文

• A network‐based predictive gene expression signature for recurrence risks in stage II colorectal cancer (2019 · Cancer Medicine · 被引 44)
• Graph-Transformer-based Surrogate Model for Accelerated Converter Circuit Topology Design (2024 · 被引 9)
• Phase 1 trial of SHR-A2102, a nectin-4–directed antibody drug conjugate (ADC), in advanced solid tumors. (2025 · Journal of Clinical Oncology · 被引 6)
• Shrinkage-controlled hydrothermal carbon: An advanced interphase for achieving synergistic stress dispersion and load transfer in Cf/ZrB2-SiC composites (2024 · Ceramics International · 被引 3)
• [Summary of clinical research progression of apatinib combined with docetaxel in second-line treatment of advanced gastric cancer]. (2020 · PubMed · 被引 3)
• Identification of Phytophthora sojae genes involved in asexual sporogenesis (2009 · Journal of Genetics · 被引 3)